Artículos por temáticas

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu

Lancet. 2025 Feb 22;405(10479):627-636. doi: 10.1016/S0140-6736(24)02808-3. Epub 2025 Feb 4.

Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review

Rossi M, Schaake S, Usnich T, Boehm J, Steffen N, Schell N, Krüger C, Gül-Demirkale T, Bahr N, Kleinz T, Madoev H, Laabs BH, Gan-Or Z, Alcalay RN, Lohmann K, Klein C.

Mov Disord. 2025 Feb 10. doi: 10.1002/mds.30141. Online ahead of print.

Low-Frequency Deep Brain Stimulation in Non-Rapid Eye Movement Sleep Modifies Memory Retention in Parkinson's Disease

Herz DM, Blech J, Winter Y, Gonzalez-Escamilla G, Groppa S.

Mov Disord. 2025 Feb;40(2):285-291. doi: 10.1002/mds.30064. Epub 2024 Nov 21.

The First Case of Autosomal Recessive Cerebellar Ataxia with Prominent Paroxysmal Non-kinesigenic Dyskinesia Caused by a Truncating FGF14 Variant in a Turkish Patient

Türkdoğan D, Smolina N, Tekgül Ş, Gül T, Yeşilyurt A, Houlden H, Zuchner S, Brais B, Pellerin D, Başak AN.

Mov Disord. 2025 Feb;40(2):370-375. doi: 10.1002/mds.30087. Epub 2024 Dec 20.

[How to use clinical neurophysiology in functional neurological disorders (FND)?]

Ugawa Y.

Rinsho Shinkeigaku. 2025 Jan 29;65(1):1-7. doi: 10.5692/clinicalneurol.cn-002050. Epub 2024 Dec 21.

Effectiveness of Spine Correction Belt for Treatment of Diaphragmatic Flutter

Kazama Y, Ando Y, Suzuki M, Sato J.

Tremor Other Hyperkinet Mov (N Y). 2025 Feb 14;15:6. doi: 10.5334/tohm.967. eCollection 2025.

Validation of Parkinson's Disease Ascertainment in the Veterans Administration Electronic Medical Record

Goldman SM, Weaver FM, Cao L, Gonzalez B, Stroupe KT, Colletta K, Jugnundan S, Brown EG, Tanner CM.

Mov Disord. 2025 Feb;40(2):245-253. doi: 10.1002/mds.30075. Epub 2024 Dec 4.

Awake versus asleep deep brain stimulation for Parkinson's disease: a comprehensive systematic review and meta-analysis

Maroufi SF, Fallahi MS, Hosseinzadeh Asli S, Khorasanizadeh M, Pour-Rashidi A, Ponce FA, Slavin KV.

J Neurosurg. 2024 Aug 16;142(2):324-338. doi: 10.3171/2024.4.JNS232553. Print 2025 Feb 1.

Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study

Freire-Álvarez E, Ramírez IL, García-Ramos R, Carrillo F, Santos-García D, Gómez-Esteban JC, Martínez-Castrillo JC, Martínez-Torres I, Madrid-Navarro CJ, Pérez-Navarro MJ, Valero-García F, Vives-Pasto

Comput Biol Med. 2025 Feb;185:109504. doi: 10.1016/j.compbiomed.2024.109504. Epub 2024 Dec 4.

Review of mesenchymal stem cell-derived exosomes and their potential therapeutic roles in treating rheumatoid arthritis

Aghajani S, Maboudi SA, Seyhoun I, Nia RR, Shabestari AN, Sharif S, Daneshi M, Verdi J.

Mol Biol Rep. 2025 Feb 13;52(1):229. doi: 10.1007/s11033-025-10290-z.

Sustained Clinical Benefit of Adaptive Deep Brain Stimulation in Parkinson's Disease Using Gamma Oscillations: A Case Report

Cernera S, Oehrn CR, Hammer LH, Shcherbakova M, Yao J, Hahn A, Wang S, Ostrem JL, Little S, Starr PA.

Mov Disord. 2025 Feb;40(2):345-350. doi: 10.1002/mds.30076. Epub 2024 Dec 4.

The complexities in the differential diagnosis of restless legs syndrome (Willis-Ekbom disease)

Poplawska-Domaszewicz K, Rota S, Qamar MA, Chaudhuri KR.

Expert Rev Neurother. 2025 Feb;25(2):157-173. doi: 10.1080/14737175.2025.2450639. Epub 2025 Jan 14.

Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications

Atterling Brolin K, Schaeffer E, Kuri A, Rumrich IK, Schumacher Schuh AF, Darweesh SKL, Kaasinen V, Tolppanen AM, Chahine LM, Noyce AJ.

Mov Disord. 2025 Feb;40(2):204-221. doi: 10.1002/mds.30067. Epub 2024 Nov 27.

In PD, Non-Invasive Trans-Spinal Magnetic Stimulation Enhances the Effect of Transcranial Magnetic Stimulation on Axial Motor Symptoms: A Double-Blind Randomized Clinical Trial

Khedr EM, Haridy NA, Korayem MA, Tawfik AM, Hamed AA.

Neurorehabil Neural Repair. 2025 Feb;39(2):126-137. doi: 10.1177/15459683241300547. Epub 2024 Dec 11.

Reversible Perfusion Changes during Acute Attacks in Glucose Transporter Type 1 Deficiency Syndrome: A Pediatric Case Series

Pacchiano F, Doneda C, Arrigoni F, Tortora M, Contaldo MT, Lomonaco G, Previtali R, Olivotto S, Veggiotti P, Parazzini C, Righini A.

AJNR Am J Neuroradiol. 2025 Feb 3;46(2):395-400. doi: 10.3174/ajnr.A8506.